Complement C3 is a novel modulator of the anti-factor VIII immune response
Development of neutralizing antibodies against therapeutic Factor VIII (FVIII) is the most serious complication of the treatment of hemophilia A. There is growing evidence to show the multifactorial origin of the anti-FVIII immune response, combining both genetic and environmental factors. While a r...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Ferrata Storti Foundation
2018-02-01
|
| Schriftenreihe: | Haematologica |
| Online-Zugang: | https://haematologica.org/article/view/8358 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|